MIROSTIPEN
UNII OF5C04223V

Substance Identification & Data

This profile provides standardized clinical and technical data for Mirostipen, uniquely identified by the FDA Unique Ingredient Identifier (UNII) OF5C04223V.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 244130-01-6 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
OF5C04223V
CAS Registry Number
244130-01-6
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
MIROSTIPEN
Official standardized name for this substance within the FDA UNII nomenclature system.
NCI Thesaurus
National Cancer Institute reference terminology for clinical and research data.
INN ID
8072
Sequential identifier assigned via the WHO International Nonproprietary Name program.
USAN ID
KK-91
Identifier assigned by the United States Adopted Names Council.
Substance Type
protein
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Mirostipen. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

MIROSTIPEN

Common Names & Synonyms

23-99-MYELOID PROGENITOR INHIBITORY FACTOR 1 (23-METHIONINE) (HUMAN)
23-L-METHIONINE-23-99-MYELOID PROGENITOR INHIBITORY FACTOR 1 (HUMAN)
MIROSTIPEN [INN]
MIROSTIPEN [USAN]
MIROSTIPEN [WHO-DD]